CAPS Town Hall Spotlight on New Projects
- This event has passed.
March 28, 2017 @ 12:00 pm - 1:00 pm PDT
CAPS Town Hall Presents:
Will Vincent, PhD, MPH; Jennifer Cocohoba, PharmD;
Maria Ekstrand, PhD
Spotlight on New Projects at the Center for AIDS Prevention Studies
Tuesday, March 28th, 2017, 12-1 pm
Mission Hall, 550 16th Street, 3rd floor, AmfAR Conference Rm. 3700
Re-Engaging Vulnerable Patients Into Care: A Focus on Locating and Reaching HIV-Positive Black MSM Who Have Left Care
PI: Wilson Vincent, PhD, MPH
Up to half of HIV+ Black MSM drop out of HIV treatment. Suboptimal retention of HIV+ Black MSM in care not only affects their health, but also undermines the promise of “treatment as prevention” for reducing the disproportionate effects of HIV/AIDS on BMSM. Thus, the aim of this project is to help to locate and reach HIV+ Black MSM who have fallen out of care. This project serves as an adjunct to Dr. Vincent’s intervention-development research to re-engage these men back into care. Will Vincent is Assistant Professor of Medicine at UCSF with prior training in clinical and community psychology and epidemiology. Dr. Vincent is interested in developing interventions to engage and re-engage vulnerable patient populations in treatment and care.
Understanding long-term prescription opioid use in HIV+ women
PI: Jennifer Cocohoba, PharmD
Women are at high risk of mortality due to opioid overuse and women living with HIV may be a particularly vulnerable population. This cohort study aims to understand factors associated with HIV+ women using prescription opioids over extended periods of time, as well as their experiences with and opinions about the impact of long term-prescription opioids on health. Jennifer Cocohoba is Professor in the UCSF School of Pharmacy. Her research focuses on adherence to antiretrovirals and other medications used in treatment of chronic diseases.
TEL-ME-BOX: Validating and Testing a Novel, Low-Cost, Real-Time Monitoring Device with Hair Level Analysis Among Adherence-Challenged Patients
PI: Maria Ekstrand, PhD, Monica Gandhi, MD, MPH
Novel, validated methods to monitor adherence to HIV treatment in real time are urgently needed given the limitations of current measures. In response to this need, Dr. Ekstrand’s Indo-US team developed “Tel-Me-Box,” a small, low-cost, real time adherence-monitoring device which is rechargeable and can be programmed to deliver tailored real-time adherence reminders. This study will modify and validate the Tel-Me-Box device against hair ARV concentrations as a pharmacologic measure of drug ingestion. If found effective, the Tel-Me-Box and intermittent hair monitoring could have widespread utility for adherence science, in India and other LMIC. Dr. Ekstrand is Professor of Medicine, who has been working in India for over 20 years and whose primary research interests are in adherence and stigma.